190 related articles for article (PubMed ID: 32463428)
21. MicroRNA-584-3p, a novel tumor suppressor and prognostic marker, reduces the migration and invasion of human glioma cells by targeting hypoxia-induced ROCK1.
Xue H; Guo X; Han X; Yan S; Zhang J; Xu S; Li T; Guo X; Zhang P; Gao X; Liu Q; Li G
Oncotarget; 2016 Jan; 7(4):4785-805. PubMed ID: 26715733
[TBL] [Abstract][Full Text] [Related]
22. Transfer of MicroRNA via Macrophage-Derived Extracellular Vesicles Promotes Proneural-to-Mesenchymal Transition in Glioma Stem Cells.
Zhang Z; Xu J; Chen Z; Wang H; Xue H; Yang C; Guo Q; Qi Y; Guo X; Qian M; Wang S; Qiu W; Gao X; Zhao R; Guo X; Li G
Cancer Immunol Res; 2020 Jul; 8(7):966-981. PubMed ID: 32350000
[TBL] [Abstract][Full Text] [Related]
23. Glioma EVs Contribute to Immune Privilege in the Brain.
Abels ER; Broekman MLD; Breakefield XO; Maas SLN
Trends Cancer; 2019 Jul; 5(7):393-396. PubMed ID: 31311653
[TBL] [Abstract][Full Text] [Related]
24. Upregulation of p-Smad2 contributes to FAT10-induced oncogenic activities in glioma.
Dai B; Zhang Y; Zhang P; Pan C; Xu C; Wan W; Wu Z; Zhang J; Zhang L
Tumour Biol; 2016 Jul; 37(7):8621-31. PubMed ID: 26733179
[TBL] [Abstract][Full Text] [Related]
25. MicroRNA-628-5p inhibits cell proliferation in glioma by targeting DDX59.
Xie P; Wang Y; Liao Y; Han Q; Qiu Z; Chen Y; Zuo X
J Cell Biochem; 2019 Oct; 120(10):17293-17302. PubMed ID: 31111544
[TBL] [Abstract][Full Text] [Related]
26. The novel chromatin architectural regulator SND1 promotes glioma proliferation and invasion and predicts the prognosis of patients.
Yu L; Xu J; Liu J; Zhang H; Sun C; Wang Q; Shi C; Zhou X; Hua D; Luo W; Bian X; Yu S
Neuro Oncol; 2019 Jun; 21(6):742-754. PubMed ID: 30753603
[TBL] [Abstract][Full Text] [Related]
27. MiR-1247-5p Functions as a Tumor Suppressor in Human Astroglioma Cells by Targeting
Liu Q; Dong Z; Chen T
Ann Clin Lab Sci; 2020 Mar; 50(2):182-189. PubMed ID: 32366555
[TBL] [Abstract][Full Text] [Related]
28. DNA sequences within glioma-derived extracellular vesicles can cross the intact blood-brain barrier and be detected in peripheral blood of patients.
García-Romero N; Carrión-Navarro J; Esteban-Rubio S; Lázaro-Ibáñez E; Peris-Celda M; Alonso MM; Guzmán-De-Villoria J; Fernández-Carballal C; de Mendivil AO; García-Duque S; Escobedo-Lucea C; Prat-Acín R; Belda-Iniesta C; Ayuso-Sacido A
Oncotarget; 2017 Jan; 8(1):1416-1428. PubMed ID: 27902458
[TBL] [Abstract][Full Text] [Related]
29. Tumor-derived extracellular vesicles: Regulators of tumor microenvironment and the enlightenment in tumor therapy.
Chen J; Fei X; Wang J; Cai Z
Pharmacol Res; 2020 Sep; 159():105041. PubMed ID: 32580030
[TBL] [Abstract][Full Text] [Related]
30. IL-3R-alpha blockade inhibits tumor endothelial cell-derived extracellular vesicle (EV)-mediated vessel formation by targeting the β-catenin pathway.
Lombardo G; Gili M; Grange C; Cavallari C; Dentelli P; Togliatto G; Taverna D; Camussi G; Brizzi MF
Oncogene; 2018 Mar; 37(9):1175-1191. PubMed ID: 29238040
[TBL] [Abstract][Full Text] [Related]
31. The role of transcriptional coactivator TAZ in gliomas.
Li W; Dong S; Wei W; Wang G; Zhang A; Pu P; Jia Z
Oncotarget; 2016 Dec; 7(50):82686-82699. PubMed ID: 27764783
[TBL] [Abstract][Full Text] [Related]
32. Microglia-glioma cross-talk: a two way approach to new strategies against glioma.
Arcuri C; Fioretti B; Bianchi R; Mecca C; Tubaro C; Beccari T; Franciolini F; Giambanco I; Donato R
Front Biosci (Landmark Ed); 2017 Jan; 22(2):268-309. PubMed ID: 27814616
[TBL] [Abstract][Full Text] [Related]
33. Expression of WT1 protein and correlation with cellular proliferation in glial tumors.
Hashiba T; Izumoto S; Kagawa N; Suzuki T; Hashimoto N; Maruno M; Yoshimine T
Neurol Med Chir (Tokyo); 2007 Apr; 47(4):165-70; discussion 170. PubMed ID: 17457020
[TBL] [Abstract][Full Text] [Related]
34. Extracellular Vesicles in Brain Tumor Progression.
D'Asti E; Chennakrishnaiah S; Lee TH; Rak J
Cell Mol Neurobiol; 2016 Apr; 36(3):383-407. PubMed ID: 26993504
[TBL] [Abstract][Full Text] [Related]
35. CD38 deficiency in the tumor microenvironment attenuates glioma progression and modulates features of tumor-associated microglia/macrophages.
Levy A; Blacher E; Vaknine H; Lund FE; Stein R; Mayo L
Neuro Oncol; 2012 Aug; 14(8):1037-49. PubMed ID: 22700727
[TBL] [Abstract][Full Text] [Related]
36. The Impact of Oncogenic EGFRvIII on the Proteome of Extracellular Vesicles Released from Glioblastoma Cells.
Choi D; Montermini L; Kim DK; Meehan B; Roth FP; Rak J
Mol Cell Proteomics; 2018 Oct; 17(10):1948-1964. PubMed ID: 30006486
[TBL] [Abstract][Full Text] [Related]
37. Suppression of SIRT6 by miR-33a facilitates tumor growth of glioma through apoptosis and oxidative stress resistance.
Chang M; Qiao L; Li B; Wang J; Zhang G; Shi W; Liu Z; Gu N; Di Z; Wang X; Tian Y
Oncol Rep; 2017 Aug; 38(2):1251-1258. PubMed ID: 28677777
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of serum extracellular vesicles as noninvasive diagnostic markers of glioma.
Wang H; Jiang D; Li W; Xiang X; Zhao J; Yu B; Wang C; He Z; Zhu L; Yang Y
Theranostics; 2019; 9(18):5347-5358. PubMed ID: 31410219
[No Abstract] [Full Text] [Related]
39. RBM17 controls apoptosis and proliferation to promote Glioma progression.
Lu J; Li Q; Cai L; Zhu Z; Guan J; Wang C; Xia J; Xia L; Wen M; Zheng W; Su Z; Wang C
Biochem Biophys Res Commun; 2018 Oct; 505(1):20-28. PubMed ID: 30227940
[TBL] [Abstract][Full Text] [Related]
40. Gliomas Interact with Non-glioma Brain Cells via Extracellular Vesicles.
Gao X; Zhang Z; Mashimo T; Shen B; Nyagilo J; Wang H; Wang Y; Liu Z; Mulgaonkar A; Hu XL; Piccirillo SGM; Eskiocak U; Davé DP; Qin S; Yang Y; Sun X; Fu YX; Zong H; Sun W; Bachoo RM; Ge WP
Cell Rep; 2020 Feb; 30(8):2489-2500.e5. PubMed ID: 32101730
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]